Target intelligence / Profile preview

Ribonucleotide reductase class III (RNR class III)

Target
RNR class III
Molecular classification
Enzyme
01

Overview

Ribonucleotide reductase class III catalyzes the conversion of ribonucleotides to deoxyribonucleotides, providing the building blocks required for DNA synthesis in anaerobic bacteria[7]. This enzyme is a glycyl radical protein that operates under strictly anaerobic conditions, using formate or similar electron donors and is oxygen-sensitive. It is essential for bacterial proliferation and is absent in human cells, positioning it as a potential selective antibacterial drug target. There are other supporting enzymes and systems involved in bacterial DNA synthesis, such as DNA polymerases, helicases, and regulatory proteins (like DnaA for origin unwinding[1]), but RNR class III serves as the canonical, defining enzyme for anaerobic deoxyribonucleotide production[7].

Other names
RNR-IIIAnaerobic ribonucleotide reductasenrdD/nrdG (gene names)Class III ribonucleotide reductase
02

Mechanism of action

Inhibition leads to depletion of deoxyribonucleotide pools, halting DNA synthesis and cell division[7]. Some inhibitors irreversibly inactivate the glycyl radical essential for class III enzyme function (theoretically applies).

03

Biological functions

Deoxyribonucleotide synthesisDNA replicationDNA repair
04

Disease associations

InfectionAntimicrobial target
05

Safety considerations

Off-target inhibition may affect endogenous RNRs in host or microbiotaRapid emergence of resistancePotential cytotoxicity if eukaryotic RNRs are also inhibited
06

Interacting drugs

Hydroxyurea (general RNR inhibitor, not selective for class III)

2 more in the full profile.

07

Biomarkers

Expression of nrdD/nrdG genesReduced RNR activity can indicate DNA synthesis inhibition

Beyond the preview

Go deeper on Ribonucleotide reductase class III (RNR class III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonucleotide reductase class III (RNR class III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call